A breakthrough pancreatic cancer drug won approval. They still struggle to access it — Live Feedhttps://www.live-feeds.com/feed/a-breakthrough-pancreatic-cancer-drug-won-approval-they-still-struggle-to-access-itContinuously updated, source-cited coverage. Newly Approved Pancreatic Cancer Drug Faces Access Hurdleshttps://www.live-feeds.com/feed/a-breakthrough-pancreatic-cancer-drug-won-approval-they-still-struggle-to-access-ithttps://www.live-feeds.com/feed/a-breakthrough-pancreatic-cancer-drug-won-approval-they-still-struggle-to-access-it#u63661Thu, 10 Sep 2026 07:10:57 +0000A newly approved breakthrough pancreatic cancer drug faces severe patient access hurdles despite its regulatory green light. Oncologists hail the medication as a treatment breakthrough and credit institutions like MD Anderson with playing a role in the FDA approval process. However, the high financial cost creates significant barriers for patients trying to obtain the therapy. Medical professionals continue to evaluate the implications of precision oncology for previously difficult targets, even as affordability and distribution problems restrict daily clinical use.Why it mattersThe therapy re